Abstract
AbstractCharcot-Marie-Tooth disease type 1 A (CMT1A) lacks an effective treatment. We provide a therapy for CMT1A, based on siRNA conjugated to squalene nanoparticles (siRNA PMP22-SQ NPs). Their administration resulted in normalization of Pmp22 protein levels, restored locomotor activity and electrophysiological parameters in two transgenic CMT1A mouse models with different severity of the disease. Pathological studies demonstrated the regeneration of myelinated axons and myelin compaction, one major step in restoring function of myelin sheaths. The normalization of sciatic nerve Krox20, Sox10 and neurofilament levels reflected the regeneration of both myelin and axons. Importantly, the positive effects of siRNA PMP22-SQ NPs lasted for three weeks, and their renewed administration resulted in full functional recovery. Beyond CMT1A, our findings can be considered as a potent therapeutic strategy for inherited peripheral neuropathies. They provide the proof of concept for a new precision medicine based on the normalization of disease gene expression by siRNA.
Funder
Agence Nationale de la Recherche
Publisher
Springer Science and Business Media LLC
Subject
General Agricultural and Biological Sciences,General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference57 articles.
1. Jerath, N. U. & Shy, M. E. Hereditary motor and sensory neuropathies: understanding molecular pathogenesis could lead to future treatment strategies. Biochim. Biophys. Acta 1852, 667–678 (2015).
2. Cutrupi, A. N., Brewer, M. H., Nicholson, G. A. & Kennerson, M. L. Structural variations causing inherited peripheral neuropathies: a paradigm for understanding genomic organization, chromatin interactions, and gene dysregulation. Mol. Genet. Genom. Med. 6, 422–433 (2018).
3. Laura, M., Pipis, M., Rossor, A. M. & Reilly, M. M. Charcot-Marie-Tooth disease and related disorders: an evolving landscape. Curr. Opin. Neurol. 32, 641–650 (2019).
4. Pipis, M., Rossor, A. M., Laura, M. & Reilly, M. M. Next-generation sequencing in Charcot-Marie-Tooth disease: opportunities and challenges. Nature reviews. Neurology 15, 644–656 (2019).
5. Manganelli, F. et al. Nerve conduction velocity in CMT1A: what else can we tell? Eur. J. Neurol. 23, 1566–1571 (2016).
Cited by
32 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献